Sugi Predict

Sugi Predict / Compounds / SCHEMBL3517883

SCHEMBL3517883

SCHEMBL3517883

CC(C)CN(Cc1ccc2c(c1)OCCCO2)C(=O)C1CN(Cc2cccnc2Cl)CCO1

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PROKR2 Q8NFJ6 5/20 0.63
▸ KDM4E B2RXH2 3/20 0.37
▸ GAA P10253 2/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ GRN P28799 1/20 0.36
▸ SORT1 Q99523 1/20 0.36
▸ POLB P06746 2/20 0.36
▸ SSTR3 P32745 1/20 0.35
▸ LMNA P02545 2/20 0.34
▸ PMP22 Q01453 1/20 0.34
▸ ALDH1A1 P00352 3/20 0.34
▸ MCHR1 Q99705 2/20 0.34
▸ HPGD P15428 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ RAB9A P51151 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3524369 0.90 PROKR2 (0.64) PROKR2KDM4EGAAKMT2APOLB
SCHEMBL3516681 0.90 PROKR2 (0.58) PROKR2KDM4EGAAKMT2ASSTR3
SCHEMBL12993038 0.89 PROKR2 (0.57) PROKR2KDM4EGAAKMT2AGRN
SCHEMBL3516679 0.88 PROKR2 (0.64) PROKR2KDM4EGAAKMT2AGRN
SCHEMBL3518194 0.88 PROKR2 (0.64) PROKR2KDM4EGAAKMT2AGRN
SCHEMBL3520517 0.87 PROKR2 (0.55) PROKR2KDM4EGAAKMT2APOLB
SCHEMBL3520285 0.87 PROKR2 (0.59) PROKR2KDM4EGAAKMT2APOLB
SCHEMBL3520269 0.87 PROKR2 (0.61) PROKR2KDM4EKMT2AGRNSORT1
SCHEMBL3518160 0.87 PROKR2 (0.62) PROKR2KDM4EGAAKMT2AGRN
SCHEMBL3517508 0.87 PROKR2 (0.63) PROKR2KDM4EGAAKMT2AGRN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1959959-B1 MORPHOLINE CARBOXAMIDE PROKINETICIN RECEPTOR ANTAGONISTS MERCK SHARP & DOHME (US) 2013-04-10 — — EP claimed
US-20090306076-A1 Morpholine Carboxamide Prokineticin Receptor Antagonists MERCK SHARP & DOHME LLC 2009-12-10 — — US claimed
US-7855201-B2 Morpholine carboxamide prokineticin receptor antagonists Merck Sharp & Dohme. Corp. (US) 2010-12-21 — — US disclosed
US-7855201-B2 Morpholine carboxamide prokineticin receptor antagonists Merck Sharp & Dohme. Corp. (US) 2010-12-21 — — US disclosed
US-7855201-B2 Morpholine carboxamide prokineticin receptor antagonists Merck Sharp & Dohme. Corp. (US) 2010-12-21 — — US disclosed
US-20090306076-A1 Morpholine Carboxamide Prokineticin Receptor Antagonists MERCK SHARP & DOHME LLC 2009-12-10 — — US disclosed
US-20090306076-A1 Morpholine Carboxamide Prokineticin Receptor Antagonists MERCK SHARP & DOHME LLC 2009-12-10 — — US disclosed
US-20090306076-A1 Morpholine Carboxamide Prokineticin Receptor Antagonists MERCK SHARP & DOHME LLC 2009-12-10 — — US disclosed
WO-2007067511-A2 MORPHOLINE CARBOXAMIDE PROKINETICIN RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 2007-06-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090306076-A1 Morpholine Carboxamide Prokineticin Receptor Antagonists PROKR2, PROKR1, NTSR2 PROKR2 1/4885KDM4E 4734/4885GAA 773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.